Roselabs Bioscience, a group company of Roselabs, has inked loan-licence pact with Hyderabad-based vaccine maker Bharat Biotech for pre-filled syringes (PFS). As part of the pact, Bharat Biotech would use the pre-filled syringe manufacturing facility of Roselabs to manufacture pre-filled syringes for its vaccines.
Roselabs Bioscience and Roselabs Polymers have invested over Rs 400 crore to set up 'pre-filled syringes' (PFS) making facility near Ahmedabad with a capacity to manufacture 8 lakh syringes per day. The company’s facility near Ahmedabad has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes.
Roselab Biosciences, which manufactures glass pre-filled syringes, pre-fillable syringes, formulations and cytotoxic Active Pharmaceutical Ingredients (API) and Roselab Polymers, which delivers sterile, clean and ready to fill pre-fillable polymer syringes, are the group companies of Roselabs.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: